@ Diagnostic Imaging Europe (DI Europe)

Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent Gadoquatrane at ECR 2026

At European Congress of Radiology (ECR) 2026, Bayer highlighted new developments in MRI technologies and contrast agents aimed at improving diagnostic efficiency and patient care.

Events

ECR 2026: DeepHealth and Gleamer Outline Vision for AI Scale and Consolidation in Radiology

Growing adoption of AI in radiology is driving demand for larger integrated platforms

Events

ECR 2026: Bracco Showcases AI-Powered Brain MRI Solution AiMIFY

Bracco explores how AI can complement contrast media in next-generation imaging workflows

Events

Radiology under pressure: lessons from disaster, war and cyberattacks at ECR 2026

Radiology leaders at ECR 2026 shared frontline lessons on how imaging departments can prepare for and respond to disasters.

Insights

Photo: ECR 2026: Lunit Highlights Decade of AI Development and Growing Clinical...

ECR 2026: Lunit Highlights Decade of AI Development and Growing Clinical Evidence

Academic studies and clinician-led research continue to test and validate Lunit’s AI tools

Photo: ECR 2026: Bayer Advances Precision Diagnostics with New Molecular...

ECR 2026: Bayer Advances Precision Diagnostics with New Molecular Imaging Agents

New radiodiagnostic tracers aim to enable earlier and more precise detection of diseases such as cardiac amyloidosis

Photo: ECR 2026: DeepHealth and Gleamer Outline Vision for AI Scale and...

ECR 2026: DeepHealth and Gleamer Outline Vision for AI Scale and Consolidation in Radiology

Growing adoption of AI in radiology is driving demand for larger integrated platforms

ECR 2026: Bracco Showcases AiMIFY

AI-Powered Brain MRI Solution

At this position you may find an embedded video from Vimeo.

When displayed, personal data (such as IP address) is transferred to Vimeo.

Please read Vimeo's privacy policy for detailed information.

Display external content

Photo: Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent...

Bayer Spotlights Next-Generation MRI and Low-Dose Contrast Agent Gadoquatrane at ECR 2026

At European Congress of Radiology (ECR) 2026, Bayer highlighted new developments in MRI technologies and contrast agents aimed at improving diagnostic efficiency and patient care.

News

DeepHealth Secures CE Mark for TechLive Remote Imaging Platform

Esaote Unveiled New Ultrasound Systems and AI Imaging Tools at ECR 2026

AB-CT Launches Photon-Counting Breast CT in Australia with First Melbourne Installation

Bayer Presents New Data for Contrast Agent Gadoquatrane from Phase III Program at ECR 2026

ECR 2026 Introduces First Alzheimer’s Day Highlighting Imaging in Dementia Car

RadNet Expands AI Imaging Ambitions with Gleamer Acquisition

Bayer Presents Phase III Cardiac MRI Data for Low-Dose Gadoquatrane

BrightHeart AI Platform Now Available via GE HealthCare Voluson Solution Store

ECR 2026 Highlights Education, AI, and Global Exchange in Radiology

GE HealthCare Receives FDA Clearance and CE Mark for Allia Moveo

Guerbet Highlights Centenary and Imaging Portfolio at ECR 2026

Handheld Ultrasound Shows Advantages in Second-Look Breast Imaging

Bayer to Present Phase III Gadoquatrane Data at ECR 2026

Planmed XFI Weight-Bearing CT Earns CE MDR Certification

NHS Fife Cuts MRI Scan Times Over 20% With Siemens AI

MRI Connectivity Patterns May Help Predict TBI Recovery

Brainomix AI Supports Phase II Stroke Trial Analysis

Butterfly Network to Open 3D Beam Steering Technology to Developers

ASE Reviews 2025 Advocacy Priorities in Cardiovascular Imaging

Bayer Expands Radiology Portfolio Into Diagnostic Tracers

Insights

Photo: Radiology under pressure: lessons from disaster, war and cyberattacks at...

Radiology under pressure: lessons from disaster, war and cyberattacks at ECR 2026

Radiology leaders at ECR 2026 shared frontline lessons on how imaging departments can prepare for and respond to disasters.

DeepHealth Advances AI-Driven Imaging Workflows and Population Health

Addressing Workflow Fragmentation in Radiology with Unified Imaging Platforms

Imaging risks for the most vulnerable patients

Possibilities to improve imaging and reduce exposure

Photo: Rewriting the Standard of Care: How Cardiac CTA Is Transforming Outcomes...

Rewriting the Standard of Care: How Cardiac CTA Is Transforming Outcomes From Diagnosis to Prevention — and Toward Asymptomatic Screening

RSNA 2025 made one thing unmistakably clear: Cardiac CT angiography (CCTA) has reached a turning point—and it is beginning to redefine how we detect and prevent heart disease.

The Digital Twin Revolution in Radiology and Radiation Oncology

Experts from Emory University discuss how digital twin technology is transforming imaging precision, adaptive therapy, and the future of personalized care